
Seroba Life Sciences
Europe, Dublin, Ireland, Dublin'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Description
Seroba is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies.
Investor Profile
Seroba Life Sciences has made 45 investments, with 6 in the past 12 months and 36% as lead.
Stage Focus
- Series A (36%)
- Series B (33%)
- Series Unknown (18%)
- Series D (4%)
- Series C (4%)
- Private Equity (2%)
- Seed (2%)
Country Focus
- Ireland (36%)
- United Kingdom (27%)
- United States (13%)
- Switzerland (7%)
- France (4%)
- The Netherlands (4%)
- Canada (4%)
- Spain (2%)
- Italy (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Therapeutics
- Pharmaceutical
- Manufacturing
- Clinical Trials
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.